The Centers for Medicare & Medicaid Services yesterday released guidance for state Medicaid agencies implementing Section 5052 of the SUPPORT for Patients and Communities Act of 2018, which gives states the option to cover substance use disorder treatment and withdrawal management services for adults who reside primarily in an eligible institution for mental diseases. The guidance provides information on the new state plan option, including requirements related to beneficiary and provider eligibility, clinical screenings, continuum of care, care transitions, and maintenance of existing expenditures.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services yesterday released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s…
Headline
State Medicaid programs are reporting an uptick in enrollment compared with their fiscal year 2020 projections, due in part to the COVID-19 pandemic. The…
Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Substance Abuse and Mental Health Services Administration Friday awarded $450 million in grants, including $250 million in emergency COVID-19 funding, to…
Headline
The Centers for Medicare & Medicaid Services yesterday approved a state of Washington-developed emergency demonstration project to adjust its Medicaid…
Headline
The Oklahoma Health Care Authority this week asked the Centers for Medicare & Medicaid Services to approve a Healthy Adult Opportunity…